<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200315046784N6</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-07-15</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>effects of knee orthosis and home-based exercise  in knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>The added effect of knee orthosis with home-based exercise (tele-rehabilitation) on pain, physical function and thickness of the quadriceps muscle in patients with mild to moderate degrees of knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-07-26</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/84221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The group allocation will be performed through permuted block randomization at an assignment ratio of 1:1. For allocation concealment, the randomization codes will be kept in opaque, sealed, sequentially numbered envelopes. Sample size is estimated at 44, however, to take account of potential withdrawals, 50 patients (n=25 per group) will be recruited for the study. First, create and seal 25 treatment A envelopes, and 25 treatment B envelopes. To create a block of 6, we will select 3 treatment A envelopes, and 3 treatment B envelopes. These 6 envelopes will be shuffled thoroughly, and place this block of 6 in a separate pile. To create a block of 4, we will select 2 treatment A envelops, and 2 treatment B envelopes. Then, we will prepare additional blocks of 6 and 4 until all 25 treatment A, and B envelopes have been used. All additional blocks will be placed in their own individual piles. We will have 3 individuals piles of shuffled blocks of 6, and 8 individuals piles of shuffled blocks of 4, Blinding description: The outcome assessor will be blinded to group allocation, because all dependent variables will be measured without the orthosis and  the patients will remove their orthosis  before referring for post-intervention assessment. Furthermore, all data will be encoded to prevent bias and to blind the statistician.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Knee Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: home-based exercise, and also flexible knee orthosis. Participants will be asked to wear flexible knee orthosis for 8 weeks except when sleeping or showering. Participants will receive 3 home-based exercise sessions (each session 30-40 minutes) per week for 8 weeks. Exercises will include: Passive knee flexion, Passive knee extension, Isometric quadriceps contraction, Supine Straight leg lift, Leg lift in prone position, Shifting the center of mass, Resistance knee flexion, Resistance knee extension. Intervention 2: Intervention group: home based exercise. They will receive the same exercises as the other group, but they will not receive knee orthosis.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is It is not yet known if there will be a plan to make this available</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Azadinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari st., Mother Sq., Mirdamad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azadinia.fatemeh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Fatemeh Azadinia</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahnazari st., Mother Sq., Mirdamad Blvd</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1545913487</zip>
        <telephone>+98 21 2222 8051</telephone>
        <email>azadinia.fatemeh@yahoo.com</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Kellgren and Lawrence grade 2 or 3 according to AP knee radiographs
Pain intensity greater than 4 based on VAS
standing and walking without assistance
50 - 65 years old</inclusion_criteria>
      <agemin>50 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of surgery or trauma in osteoarthritic limb
Physical therapy, chiropractic, or acupuncture treatment, or knee-specific exercises in the past 6 months
oral or intra-articular corticosteroid use within the past 6 months or any other intra-articular injections such as hyaluronic acid or PRP
Uncontrolled blood pressure, heart disease, insulin-dependent diabetes, impaired kidney function, use of medications that cause dizziness, nervous system disorders, taking muscle relaxant medications
history of wearing knee orthoses in past 6 months
allergic skin reaction
other types of arthritis such as Rheumatoid arthritis
BMI&gt;30</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: home-based exercise, and also flexible knee orthosis. Participants will be asked to wear flexible knee orthosis for 8 weeks except when sleeping or showering. Participants will receive 3 home-based exercise sessions (each session 30-40 minutes) per week for 8 weeks. Exercises will include: Passive knee flexion, Passive knee extension, Isometric quadriceps contraction, Supine Straight leg lift, Leg lift in prone position, Shifting the center of mass, Resistance knee flexion, Resistance knee extension.</i_keyword>
      <i_keyword>Intervention group: home based exercise. They will receive the same exercises as the other group, but they will not receive knee orthosis.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain via visual analog scale(VAS). Timepoint: Before and after 8 weeks intervention. Method of measurement: visual analog scale(VAS).</prim_outcome>
      <prim_outcome>Physical function. Timepoint: Before and after 8 weeks intervention. Method of measurement: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quadriceps muscle thickness. Timepoint: before and after 8 weeks intervention. Method of measurement: Ultrasound.</sec_outcome>
      <sec_outcome>Functional mobility via Timed-Up and Go (TUG). Timepoint: before and after 8 weeks intervention. Method of measurement: TUG: measuring the time to get up from a chair, walking at  certain distance, turn around, return to the chair, and sitting down again.</sec_outcome>
      <sec_outcome>Kinesiophobia. Timepoint: before and after 8 weeks intervention. Method of measurement: Tampa scale.</sec_outcome>
      <sec_outcome>Lower limb muscles function via sit-to-stand test. Timepoint: before and after 8 weeks intervention. Method of measurement: Counting the number of times the patient comes to a full standing position during 30 sec.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2025-05-25</approval_date>
        <contact_name>Research Ethics Committees of Iran University of Medical Sciences</contact_name>
        <contact_address>Shahid Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
